COVID-19 Vaccine Development & Implementation Workshop 2021 - June Edition

What's New

• Enduring materials are now available on this website.

Thank You Message

The workshop on COVID-19 Vaccine Development & Implementation Workshop 2021 - June Edition was held virtually on 29 - 30 June 2021. Please visit the Enduring Materials tab for related slidesets and videos of our faculty to this workshop.

The COVID-19 Vaccine Development & Implementation Workshop aimed to increase knowledge and facilitate discussion on the many aspects of vaccine development and rollout on a background of a firm understanding of pathogenesis and natural infection. Our goal was to address the many scientific, social, and policy challenges in the totality of delivering an effective COVID-19 vaccine.

This global program hoped to promote understanding and stimulate further discussion and research among virologists, infectious diseases specialists, community, and policymakers. This was done in the truly global context of the COVID-19 pandemic, considering regional differences in access to medications, health system capacity, and public measures.

Topics of Interest

• Emerging clinical data for several more vaccines being approved in the meantime;
• Impact of vaccination on country rates of COVID-19;
• Durability of immunity;
• Vaccines in children; and
• Impact of new virus variants on protection.

Who Should Attend

• Virologists, immunologists, and scientists involved or interested in vaccine research and physicians caring for COVID-19 patients;
• Nurses, and other healthcare professionals involved in the care of COVID-19; patients, policymakers, and (non)government representatives; and
• Healthcare administrators.

Learning Objectives

At the completion of the program participants will:

• Acquire up-to-date knowledge on COVID-19 epidemiology, vaccination rates, and safety and toxicity data
• Comprehend the impact of new SARS-CoV-2 variants on vaccine efficacy and effectiveness
• Increase understanding of SARS-CoV-2 diagnostics, including emerging variants
• Increase knowledge on the COVID-19 vaccine development
• Understand vaccine-induced protection against infection and transmission, both in real-world settings and modeling studies

Disclaimer

This program is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this program, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this program. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the program.